LABCORP HOLDINGS INC. Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment
LABCORP HOLDINGS INC. (LH) reported Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment of $0 for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-30.
Discontinued › Income Statement › Other Income
us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1 · last filed 2018-10-30
- LABCORP HOLDINGS INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to settlement and curtailment for the quarter ending 2018-09-30 was $0.00.
- LABCORP HOLDINGS INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to settlement and curtailment for the quarter ending 2018-06-30 was $0.00.
- LABCORP HOLDINGS INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to settlement and curtailment for the quarter ending 2018-03-31 was $0.00.
- LABCORP HOLDINGS INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to settlement and curtailment for the quarter ending 2017-09-30 was -$100.00K.
| Period end | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment 3 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment 6 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment 9 month |
|---|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-10-30 | $0.00 derived: sum of 2 quarters · filed 2018-10-30 | $0.00 10-Q · filed 2018-10-30 |
| 2018-06-30 | $0.00 10-Q · filed 2018-07-27 | $0.00 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-01 | ||
| 2017-09-30 | -$100.00K 10-Q · filed 2018-10-30 | -$200.00K derived: sum of 2 quarters · filed 2018-10-30 | -$300.00K 10-Q · filed 2018-10-30 |
| 2017-06-30 | -$100.00K 10-Q · filed 2018-07-27 | -$200.00K 10-Q · filed 2018-07-27 | |
| 2017-03-31 | -$100.00K 10-Q · filed 2018-05-01 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-02 | $0.00 10-Q · filed 2017-08-02 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |